埃斯頓(002747.SZ):南京鼎控擬9400萬元將揚州曙光20%股權轉讓給曙光藍風啟
格隆匯6月20日丨埃斯頓(002747.SZ)公佈,為了不斷優化公司資源配置和產業佈局,聚焦核心業務,同時進一步發揮管理團隊積極性和推動揚州曙光可持續獨立發展,公司控股子公司南京鼎控擬將持有的揚州曙光20%股權轉讓給曙光藍風啟(由揚州曙光經營管理團隊和核心骨幹員工共同設立的員工持股平台),轉讓價款總額為人民幣9,400萬元。本次交易完成後,南京鼎控持有揚州曙光的股權將由68%變更為48%,曙光藍風啟將持有揚州曙光20%股權,揚州曙光不再納入上市公司合併財務報表範圍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.